4.8 Article

Impaired autophagy bridges lysosomal storage disease and epithelial dysfunction in the kidney

Journal

NATURE COMMUNICATIONS
Volume 9, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-017-02536-7

Keywords

-

Funding

  1. Fonds National de la Recherche Scientifique
  2. Fonds de la Recherche Scientifique Medicale (Brussels, Belgium)
  3. European Community's Seventh Framework Programme [305608, 608847]
  4. Cystinosis Research Foundation (Irvine, CA, USA)
  5. Swiss National Science Foundation [31003A-169850]
  6. clinical research priority programs (KFSP) Molecular Imaging Network Zurich (MINZ)
  7. RADIZ (Rare Disease Initiative Zurich) of the UZH
  8. Dutch Kidney Foundation [16OI06]
  9. Swiss National Centre of Competence in Research (NCCR) Kidney Control of Homeostasis (Kidney.CH)

Ask authors/readers for more resources

The endolysosomal system sustains the reabsorptive activity of specialized epithelial cells. Lysosomal storage diseases such as nephropathic cystinosis cause a major dysfunction of epithelial cells lining the kidney tubule, resulting in massive losses of vital solutes in the urine. The mechanisms linking lysosomal defects and epithelial dysfunction remain unknown, preventing the development of disease-modifying therapies. Here we demonstrate, by combining genetic and pharmacologic approaches, that lysosomal dysfunction in cystinosis results in defective autophagy-mediated clearance of damaged mitochondria. This promotes the generation of oxidative stress that stimulates G alpha 12/Src-mediated phosphorylation of tight junction ZO-1 and triggers a signaling cascade involving ZO-1-associated Y-box factor ZONAB, which leads to cell proliferation and transport defects. Correction of the primary lysosomal defect, neutralization of mitochondrial oxidative stress, and blockage of tight junction-associated ZONAB signaling rescue the epithelial function. We suggest a link between defective lysosome-autophagy degradation pathways and epithelial dysfunction, providing new therapeutic perspectives for lysosomal storage disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available